Olmesartan medoxomil 20 MG tab 90S
Ended Awarded
- Contract number
- SPE2DB25FQVJP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,809
Award facts
- Contract value 100% obligated
- $1,809.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Olmesartan Medoxomil 20 mg tablets (90-count) with a ceiling value of $1,809.21. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's comprehensive federal contract portfolio encompasses a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Olmesartan Medoxomil, an antihypertensive medication, exemplifies AmerisourceBergen's role in supplying essential pharmaceuticals to support Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQVJP?
SPE2DB25FQVJP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FQVJP worth?
The government has obligated $1,809 on SPE2DB25FQVJP.
Is contract SPE2DB25FQVJP an order under another contract?
Yes. SPE2DB25FQVJP is a delivery order under SPE2DB25D3001, an indefinite delivery contract.
Was contract SPE2DB25FQVJP competed?
The extent of competition for SPE2DB25FQVJP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award